CCR5 receptor expression is down-regulated in HIV type 2 infection: implication for viral control and protection

AIDS Res Hum Retroviruses. 2004 Jun;20(6):630-5. doi: 10.1089/0889222041217383.

Abstract

HIV-2 is known to display an attenuated phenotype in vivo with prolonged time to disease and decreased rate of transmission. Observational studies in Senegal have demonstrated protection from HIV-1 infection, although the putative mechanism for immunoprotection remains undefined. We evaluated HIV-2-seropositive women from a cohort of commercial sex workers in Dakar, Senegal and identified individuals with very low surface CCR5 receptor expression on CD4+ T cells. In vitro up-regulation of the CCR5 receptor was readily achieved. Down-regulation of the CCR5 was not correlated with activation markers (HLA-DR), beta-chemokine levels, or plasma viral loads. A correlation was observed with HIV-2-specific CD8+ T cell activity as measured by intracellular cytokine production. We postulate that down-regulation of the CCR5 receptor in HIV-2 infection contributes to slower disease course and to the protective mechanism against HIV-1 superinfection, mediated in part by HIV-2-specific cellular immune responses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Chemokines, CC / blood
  • Cytokines / analysis
  • Cytokines / biosynthesis
  • Disease Progression
  • Down-Regulation*
  • Female
  • Gene Expression Regulation
  • HIV Infections / physiopathology*
  • HIV Infections / virology*
  • HIV-2*
  • HLA-DR Antigens / analysis
  • Humans
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / metabolism*
  • Senegal
  • Viral Load

Substances

  • Chemokines, CC
  • Cytokines
  • HLA-DR Antigens
  • Receptors, CCR5